>>> Read the latest press release

We improve human health by speeding the creation of vaccines and monoclonal antibodies.

Boost Biopharma, Inc. is an early-stage biotechnology company with headquarters in Woburn, Massachusetts and research laboratory facilities in Madison, Wisconsin. We are honored to be working in partnership with the US National Institutes of Health (NIH/NIAID), the Coalition for Epidemic Preparedness Innovations (CEPI), and private investors.

Boost designs, engineers, and develops recombinant protein vaccine candidates. Boost also engages in antibody discovery and development for therapeutics and diagnostics.

The company is entering into clinical phase testing of its first vaccine, a next-generation SARS-CoV-2 vaccine being evaluated for intramuscular and nasal administration.

Our mission is to ‘do well by doing good’ and to create a legacy by making vaccines and therapies that improve human health for billions of people around the world.